Реваскуляризація міокарда в пацієнтів  з ішемічною хворобою серця  та цукровим діабетом

О.Й. Жарінов, В.В. Студнікова, О.А. Єпанчінцева, Б.М. Тодуров

Література

1. Aronson D., Edelman E.R. Revascularization for coronary artery disease in diabetes mellitus: Angioplasty, stents and coronary artery bypass grafting // Rev. Endocr. Metab. Disord. DOI 10.1007/s11154-010-9135-3.
2. Banning A.P., Westaby S., Morice M.C. et al. Diabetic and non-diabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents // J. Am. Coll. Cardiol.–  2010.– Vol. 55.– P. 1067–1075.
3. Boden W.E., O’Rourke R.A., Teo K.K. et al. Optimal medical therapy with or without PCI for stable coronary disease // New Engl. J. Med.– 2007.– Vol. 356.– Р. 1503–1516.
4. Breeman A., Hordijk M., Lenzen M. et al. Treatment decisions in stable coronary artery disease in a broad range of European practices. Insights from the Euro Heart Survey on coronary revascularization // J. Thor. Cardiovasc. Surg.– 2006.– Vol. 132. – Р. 1001–1009.
5. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease // New Engl. J. Med.– 1996.– Vol. 335.– P. 217–225.
6. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI) // Circulation.– 1997.– Vol. 96.– Р. 1761–1769.
7. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. The final 10-year follow-up results from the BARI randomized trial // J. Am. Coll. Cardiol.– 2007.– Vol. 49.– Р. 1600–1606.
8. Coylewright M., Blumenthal R.S., Post W. Placing COURAGE in context: review of the recent literature on managing stable coronary artery disease // Mayo Clin. Proc.– 2008.– Vol. 83.– Р. 799–805.
9. Daemen J., Boersma E., Flather M. et al. Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials // Circulation.– 2008.– Vol. 118.– Р. 1146–1154.
10. D’Ascenzo F., Bollati M., Clementi F. et al. Incidence and predictors of coronary stent thrombosis: evidence from an international collaborative meta-analysis including 30 studies, 221,066 patients, and 4276 thromboses // Int. J. Cardiol.– 2012.– Vol. 12.– Р. 1–10.
11. Farkouh M.E., Domanski M., Sleeper L.A. et al. Strategies for multivessel revascularization in patients with diabetes // New Engl. J. Med.– 2012.– Vol. 367.–  Р. 2375–2384.
12. Frye R.L., August P., Brooks M.M. et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease // New Engl. J. Med.– 2009.– Vol. 360.– Р. 2503–2515.
13. Gaede P., Lund-Andersen H., Parving H.H. et al. Effect of a multifactorial intervention on mortality in type 2 diabetes // New Engl. J. Med.– 2008.– Vol. 358.– Р. 580–591.
14. Graham I., Atar D., Borch-Johnsen K. et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary // Eur. Heart J.– 2007.– Vol. 28.– Р. 2375–2414.
15. Haffner S., Lehto S.T., Rönnemaa T. et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction // New Engl. J. Med.– 1998.– Vol. 339.– Р. 229–234.
16. Hillis L.D., Smith P.K., Anderson J.L. et al. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists and Society of Thoracic Surgeons // J. Am. Coll. Cardiol.– 2011.– Vol. 58.– Р. e123–e210.
17. Hlatky M.A. Compelling evidence for coronary-bypass surgery in patients with diabetes // New Engl. J. Med.– 2012.– Vol. 367.– P. 2437–2438.
18. Hlatky M.A., Boothroyd D.B., Bravata D.M. et al. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials // Lancet.– 2009.– Vol. 373.– Р. 1190–1197.
19. Kappetein A.P., Feldman T.E., Mack M.J. et al. Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial // Eur. Heart J.– 2011.– Vol. 32.– Р. 2125–2134.
20. Kapur A., Hall R.J., Malik I.S. et al. Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial // J. Am. Coll. Cardiol.– 2010.– Vol. 55.– Р. 432–440.
21. Lagerqvist B., Husted S., Kontny F. et al., the FRISC-II Investigators. A long-term perspective on the protective effects of an early invasive strategy in unstable coronary artery disease // JACC.– 2002.– Vol. 40.– Р. 1902–1914.
22. Luscher T.F., Creager M.A., Beckman J.A., Cosentino F. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part II // Circulation.– 2003.– Vol. 108.– Р. 1655–1661.
23. O’Keefe J.H., Blackstone E.H., Sergeant P., McCallister B.D. The optimal mode of coronary revascularization for diabetics: a risk-adjusted long-term study comparing coronary angioplasty and coronary bypass surgery // Eur. Heart J.– 1998.– Vol. 19.– Р. 1696–1703.
24. Pasterkamp G. Methods of accelerated atherosclerosis in diabetic patients // Heart.– 2013.– Vol. 99.– Р. 743–749.
25. Rutter M.K., Nesto R.W. Coronary revascularisation in the patient with diabetes: balancing risk and benefit // Heart.– 2010.– Vol. 96.– Р. 1436–1440.
26. Schwartz L., Kip K.E., Frye R.L. et al. Coronary bypass graft patency in patients with diabetes in the Bypass Angioplasty Revascularization Investigation (BARI) // Circulation.– 2002.– Vol. 106.– P. 2652–2658.
27. Stanley W.C., Ryden L. The diabetic coronary patient.– Science Press, 2003.– 76 p.
28. Stenedtrand U., Wallentin L. Early revascularization and 1-year survival in 14-days survivors of acute myocardial infarction: a prospective cohort study // Lancet.– 2002.– Vol. 359.– Р. 1805–1811.
29. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology and of the European Association for the Study of Diabetes. Guidelines on diabetes, pre-diabetes and cardiovascular disease: executive summary // Eur. Heart J.– 2007. – Vol. 28. – P. 88–136.
30. The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). ESC/EAS Guidelines for the management of dyslipidaemias // Eur. Heart J.– 2011.– Vol. 32.– P. 1769–1818.
31. The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Guidelines on myocardial revascularization // Eur. Heart J.– 2010.– Vol. 31.– P. 2501–2555.
32. Young L.H., Wackers F.J., Chyun D.A. et al. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial // JAMA.– 2009.– Vol. 301.– P. 1547–1555.